Outcome of COVID-19 and tolerance of Remdesivir in patients with renal failure: a single center experience from Pakistan
Conclusions: COVID-19 in renal failure has a high risk for ICU admissions leading to increased mortality. Multiple comorbidities and raised inflammatory markers are predictors of poor outcomes. We observed no significant drug-related adverse effects, and none of our patients required discontinuation of RDV due to worsening renal function.
Source: The Journal of Infection in Developing Countries - Category: Infectious Diseases Authors: Zaheer Udin Babar, Sunil Kumar Dodani, Asma Nasim, Jawahar Lal Langhani, Sanjay Kumar Badlani Source Type: research
More News: Chronic Kidney Disease | Coronavirus | COVID-19 | Dialysis | Infectious Diseases | Pakistan Health | Renal Failure | Study | Urology & Nephrology